Health ❯ Biotechnology ❯ Drug Development ❯ Gene Therapy

Duchenne Muscular Dystrophy

FDA Flags Possible License Revocation for Sarepta’s Elevidys

Regulators doubt that new safety measures can eliminate risks after two patients died from liver injuries.

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request